Both in Pharmaceuticals
Xilio Therapeutics vs Citius Oncology
Over the past year XLO returned −22.4% and CTOR returned −65.2%; their daily moves had a correlation of -0.07.
XLO −22.4% CTOR −65.2%Growth of $1, one year, split-adjusted
| Metric | XLO | CTOR |
|---|---|---|
| Price | $8.71 | $0.5470 |
| Market cap | $57.3M | $57.9M |
| Today | +0.35% | −0.55% |
| 1 month | −3.2% | −35.6% |
| 6 months | +10.3% | −39.8% |
| Year to date | −2.8% | −45.3% |
| 1 year | −26.8% | −67.2% |
| Revenue growth (YoY) | +131.2% | — |
| Gross margin | 100.0% | 67.1% |
| Net margin | −34.1% | −597.4% |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | 8.1× |
| Net cash | $136.0M | $10.2M |
| Dividend yield | — | — |
| Volatility (60d) | 38.3% | 98.9% |
| Short % of float | 10.1% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).